DEFINITIVE CONTRACT
Active75F40126C00082
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$256.4K
obligated · signed 2 months ago
BAA - DEVELOPMENT OF NOVEL IN VITRO DISSOLUTION METHODS FOR CHEWABLE VETERINARY
Performance timeline
Start
Sep 1, 2026
Current end
Aug 31, 2027
Potential end
Aug 31, 2029
with all options
Loading status
Estimated start: Aug 31, 2028
TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER
Contract 75F40126C00082
UEI
HFT7XTHB6563
Parent Company
TEXAS A & M UNIVERSITY SYSTEM HEALTH SCIENCE CENTER
Capabilities & Certifications
Headquarters Location
Congressional District: 10
Current Obligation
$256,446
Base + Exercised Options
$256,446
Total Ceiling Value
$867,832
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
ALL OTHER SUPPORT SERVICES
PSC
SUPPORT- PROFESSIONAL: OTHER
Place of Performance
Congressional District: 10
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.